Pharmacovigilance and Risk Management

The World Health Organization (WHO) defines pharmacovigilance as the science and activities relating to the detection, evaluation, understanding and prevention of adverse reactions to medicines or any other medicine-related problems. Pharmacovigilance is to protect patients and the public wherever possible and to disseminate knowledge among the relevant professional communities and to patients in order to minimise risk. Pharmacovigilance system or the processes to be engaged in risk management, there is consensus among the major regulators that pharmacovigilance is necessary and important in the development and commercialization of medicinal products.

  • Pharmacovigilance practice
  • Drug safety
  • Pharmacovigilance significance and scope
  • Implementation of risk minimization
  • Pharmacy practice and it’s challenges
  • Information technology in pharmacovigilance

 

    Related Conference of Pharmacovigilance and Risk Management

    Pharmacovigilance and Risk Management Conference Speakers